Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)
about
Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5.The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancerChronic nasal exposure to nanoparticulate TiO2 causes pulmonary tumorigenesis in male mice.Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung Cancer.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations.Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy.CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non-small cell lung cancer.Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients
P2860
Q34361335-E3D40DE7-9F23-464A-A346-ED69C069916CQ35380267-70EAC487-0F01-48B7-96B0-0553778D1079Q35609756-02D75763-1805-4156-82A4-893FC365A8FBQ35633965-747F299A-7689-4220-AE19-BF4E639AEC74Q36253580-42A6222A-ED5F-45BF-AA08-26CB0DB8C471Q36540802-147ADE83-2B9E-4BBC-B61B-070714EA8A4CQ36582422-D8F30FD5-1FEA-4A4A-826F-6700885AD9A9Q37458637-84A51C60-D7FC-4BBC-AC22-49B095F61B65Q38718071-8BA247BF-3318-4FFA-8BF5-4335A280E578Q38931288-245B7082-A035-44DC-A539-6571FDD3D851Q38947077-7FB23C41-60A4-4C93-8EAA-31CDF1B5E099Q41200718-0084E446-7A77-49F1-96E2-94F87C1A7E6AQ44252808-882888CB-10DD-40E9-97F8-D6746CA6D523Q47161899-3608ED13-E0DB-4C22-867F-ACCB3B6E062DQ51525251-8CA79F8A-69CF-4AEB-9961-12E7E4D2623AQ51718771-E7550A5D-3187-4D65-9207-08C710A3A834Q53323484-E4ECC885-9D59-4407-8A87-C128B1861B1BQ53496294-71A5BED6-B0F2-43A1-A0BF-739F6045C42EQ57924377-BF7AA1E0-5DB6-4D35-9E41-5AF831E1F6DE
P2860
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)
description
im Mai 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 24 April 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2011
@uk
name
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@en
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@nl
type
label
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@en
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@nl
prefLabel
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@en
Serum Tumor Markers CEA, CYFRA ...... Small-Cell Lung Cancer (NSCLC)
@nl
P2093
P1433
P1476
Serum tumor markers CEA, CYFRA ...... small-cell lung cancer (NSCLC)
@en
P2093
Davis Torrejón
Isaac Nuñez
Marina Longo
Pablo Martinez
Susana Cedrés
P304
P356
10.1016/J.CLLC.2011.03.019
P407
P577
2011-04-24T00:00:00Z